Highlights from ESMO 2024: How does it affect drug development going forward

Our expert oncologists and regulatory leaders delve into the key highlights from the recent European Society for Medical Oncology (ESMO) Congress. This session explores groundbreaking research, innovative treatment approaches, and pivotal clinical trial results presented at ESMO. Our speakers analyze how these developments may influence the strategies of other drug developers, potentially reshaping the landscape of oncology research and treatment. 

Return to Insights Center

Related Insights

Related Insights

Article

Navigating the challenges of large, international Phase III breast cancer trials

Jul 29, 2025

Blog

The potential of neoadjuvant therapy in the treatment of solid tumors

Apr 15, 2024

Article

Embarking on the Next Era of Precision Medicine

May 11, 2021

Blog

Highlights from ASCO: Our experts weigh in

Jul 13, 2021

Blog

Parexel names first Patient Ambassador

Jun 17, 2022

Blog

What Do the Next 10 Years Hold for CRISPR?

Jul 27, 2022

Show more